MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Parkinson’s"

  • 2025 International Congress

    International Mentorship in PPMI Clinical Translation (IMPaCT): Engagement Initiatives for Clinical Participants in the United States (US)

    L. Lemon, B. Mcmahon, A. Cunningham, H. Hargrave, J. Ewart, N. Alam, N. Whalen, R. Gokarn (New Haven, USA)

    Objective: Describe cohort engagement strategies conducted by PPMI IMPaCT Program among US participants. Background: Retention in longitudinal studies is vital for study for data integrity/analysis.1…
  • 2025 International Congress

    Unraveling Functional Overlay in Parkinson’s Disease: A Diagnostic Challenge

    RAM. Carandang, P. Panyakeaw (Bangkok, Thailand)

    Objective: To highlight the diagnostic complexities of functional movement disorders (FMD) in Parkinson’s disease (PD) and the role of neurophysiological studies in differentiating functional overlay…
  • 2025 International Congress

    A Scoping Review of Psychological Interventions across domains to improve Quality of Life in Persons with Parkinson’s Disease

    S. Desai, D. Desai (Anand, India)

    Objective: This scoping review examines the evidence for psychological interventions across the domains of therapy, activity, tele-health and integrated care for improving Quality of Life…
  • 2025 International Congress

    Automating the assessment of motor symptoms of Parkinson’s: exploring the scope of assessment possible in a video-based approach.

    A. Podlewska, R. Singh, M. Squires, B. Bridges (London, United Kingdom)

    Objective: To explore the scope of the PRIMS assessment in People with Parkinson’s (PwP), including symptom severity rating, assessment time, individual assessment item completion and…
  • 2025 International Congress

    End-of-life care management in Parkinson’s disease: a nationwide survey of French healthcare practitioners’ experiences and perceptions

    A. Lagarde, A. Camm Chapel, T. Cognard, M. Auffret (Paris, France)

    Objective: To describe the personal experiences and perceptions of healthcare practitioners (HCP) involved in the terminal management of people diagnosed with Parkinson's disease (PD) Background:…
  • 2025 International Congress

    Integrating Counterclockwise Theory, Mental Imagery, and Art Therapy for Parkinson’s Disease: A Proposed Protocol for Motor and Non-motor Symptom Management

    WJ. Hur, HR. Yoo, MS. Park, JW. Seo, JY. Hur (Daejeon, Republic of Korea)

    Objective: This review/protocol proposal explores whether combining three concepts Counterclockwise theory, Imagery training, and Art therapy can improve motor symptoms and enhance the quality of…
  • 2025 International Congress

    Access to Allied Health Services by People Living with Parkinson’s Disease: A Qualitative Study

    C. Wong, S. Dennis, N. Allen, S. Paul (Camperdown, Australia)

    Objective: To determine the referral patterns of people with Parkinson’s disease (PwPD) to allied health from their perspective. Background: Allied health interventions can improve impairments…
  • 2025 International Congress

    P2P Therapeutics Platform Trial in Stage 2B Neuronal Alpha-Synuclein Disease: Study Design and Statistical Considerations

    T. Simuni, C. Coffey, A. Siderowf, C. Tanner, M. Brumm, S. Chowdhury, T. Sherer, C. Kopil, K. Kieburtz, C. Allen-Savietta, B. Wendelberger, A. Crawford, T. Tropea, K. Fabrizio, H. Whalen, K. Marek (Chicago, USA)

    Objective: To describe the study design and timeline of a platform interventional study in Neuronal α-Synuclein Disease (NSD). Background: The recent description of the biological…
  • 2025 International Congress

    Smartphone-based digital assessments in the LUMA trial of BIIB122 for early-stage Parkinson’s disease

    R. Llorens Arenas, J. Edgerton, E. Bartholomé, S. Belachew, M. Gifford, J. Guo, B. Hersh, D. Jennings, C. Kanzler, E. Koca, M. Pang, O. Reyes, C. Shen, M. Wald, N. Woody, C. Mazzá (Cambridge, USA)

    Objective: To evaluate the sensitivity of routine smartphone-based performance assessments in the free-living environment as part of a randomized clinical trial in Parkinson’s disease (PD).…
  • 2025 International Congress

    Evaluation of Impact of Helicobacter Pylori Eradication on Symptomatology and Quality of Life in Parkinson’s Disease

    A. Kakkar, G. Vishwas, S. Mehta, S. Pattanaik, S. Bhattacharyya, V. Sharma, M. Modi (Chandigarh, India)

    Objective: This study aimed to determine the effects of Helicobacter Pylori(HP) eradication treatment on motor and non-motor symptoms and quality of life of PD patients…
  • « Previous Page
  • 1
  • …
  • 20
  • 21
  • 22
  • 23
  • 24
  • …
  • 436
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • “Magic carpet for freezing of gait ” Evaluating a combination of patterned and pictographic visual cues.
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley